Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett et al. · Journal of Clinical Oncology · 2010 · 4.3K citations · Full text

Medicine, Cancer Biology, Oncology +14

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Aron Goldhirsch, W. C. Wood, Alan S. Coates et al. · Annals of Oncology · 2011 · 3.9K citations · Full text

Medicine, Oncology, Breast Oncology +16

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Archives of Pathology & Laboratory Medicine · 2013 · 1.8K citations · Full text

Medicine, Oncology, Pathology +14

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

Aron Goldhirsch, James N. Ingle, Richard D. Gelber et al. · Annals of Oncology · 2009 · 1.4K citations · Full text

Medicine, Endocrinology, Oncology +16

Prognostic markers in triple‐negative breast cancer

Emad A. Rakha, Maysa E. El‐Sayed, Andrew R. Green et al. · Cancer · 2006 · 1.3K citations

Medicine, Oncology, Breast Oncology +16